Plasma Rich in Growth Factors as an Adjuvant Treatment for the Management of Frontal Fibrosing Alopecia: A Retrospective Observational Clinical Study
Journal of Cutaneous Medicine and Surgery · 2023
DOI: 10.1177/12034754231177599 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Cutaneous Medicine and Surgery, 2023. Verfasst von Alejandro García und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro Dermatológico Estético, Alicante, Spain. Hauptthemen laut MEDLINE: Alopecia, Lichen Planus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Background
Frontal fibrosing alopecia (FFA) is a scarring alopecia in which the exact etiopathogenesis has not been completely elucidated and the available treatments are not very effective. Plasma rich in growth factors (PRGF) has shown to induce folliculogenesis in hair loss related disorders. However, the scientific evidence when facing FFA is scarce.
Objectives
The aim of this study was to retrospectively analyze the adjuvant use of PRGF compared to the conventional treatment in the management of FFA.
Methods
Participants with clinically diagnosed FFA who had been treated with either conventional therapy (Control Group) or conventional therapy combined with PRGF (PRGF Group) were identified from the center’s medical records. The clinical assessment was based on the “Frontal Fibrosing Alopecia Severity Score” (FFASS), which was fulfilled during a period of two and 4 years.
Results
This study included 118 patients with clinically diagnosed FFA (Control Group: 57 and PRGF Group: 61). No adverse effects related to the treatments were observed. Both treatments showed to halt the steady progression of hair loss compared to baseline. PRGF treatment also induced significant hair regrowth compared to the Control Group. The scalp inflammation was reduced in response to treatments. The FFASS score indicated that PRGF Group improved the symptoms and severity of FFA in a significant manner.
Conclusions
The adjuvant use of PRGF may exert long-term beneficial effects on hair loss reduction and might reduce the symptoms and severity of FFA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro Dermatológico Estético, Alicante, Spain.
- BTI Biotechnology Institute, Vitoria, Spain.
ORCID-Profile: Ander Pino
Zitieren
APA
García, A., Navarro, M. R., Ramirez, A., Pino, A., Navarro, A., Moles, I., Gallego, E., & Anitua, E. (2023). Plasma Rich in Growth Factors as an Adjuvant Treatment for the Management of Frontal Fibrosing Alopecia: A Retrospective Observational Clinical Study. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754231177599
Vancouver
García A, Navarro MR, Ramirez A, Pino A, Navarro A, Moles I, et al. Plasma Rich in Growth Factors as an Adjuvant Treatment for the Management of Frontal Fibrosing Alopecia: A Retrospective Observational Clinical Study. Journal of Cutaneous Medicine and Surgery. 2023. doi:10.1177/12034754231177599
BibTeX
@article{Garca2023,
author = {García, Alejandro and Navarro, M R and Ramirez, Ana and Pino, Ander and Navarro, Ariadna and Moles, Isabel and Gallego, Estefanía and Anitua, Eduardo},
title = {Plasma Rich in Growth Factors as an Adjuvant Treatment for the Management of Frontal Fibrosing Alopecia: A Retrospective Observational Clinical Study},
journal = {Journal of Cutaneous Medicine and Surgery},
year = {2023},
doi = {10.1177/12034754231177599}
}
EUVIMED